Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
[Clinical features of 314 patients with relapsing-remitting multiple sclerosis].
Natalizumab SC Similar to IV Every 4 Weeks for MS
There is much to be learnt about the costs of multiple sclerosis in Latin America.
Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system.
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Disease course heterogeneity and OCT in multiple sclerosis.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis.
Oral therapy approved for multiple sclerosis.
Plasma exchange response in 34 patients with severe optic neuritis.
Optic neuritis revealing Kikuchi-Fujimoto's disease: clinical commentary.
Internet-based home training is capable to improve balance in multiple sclerosis: a comparative trial with hippotherapy.
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines.
Role of toll-like receptors in multiple sclerosis.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
P300 wave changes in patients with multiple sclerosis.
Acid-Sensing Ion Channels Contribute to Neurotoxicity.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pages
« first
‹ previous
…
638
639
640
641
642
643
644
645
646
…
next ›
last »